Mount Auburn Hospital Report issue

Academic/Hospital Phase 2 Phase 4

Organization Overview

First Clinical Trial
2013
NCT01905137
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Mount Auburn Hospital

Active Ingredients

Drugs in Phase 4 Trials (1)

estradiol (progynon depot) (1 trial)

Drugs in Phase 2 Trials (1)

atorvastatin (lipitor) (1 trial)

Drugs in Other Trials (1)

rimabotulinumtoxinB (Myobloc) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Hematuria (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 3
  • # of Trial APIs: 3